<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881944</url>
  </required_header>
  <id_info>
    <org_study_id>IRB_00087668</org_study_id>
    <nct_id>NCT02881944</nct_id>
  </id_info>
  <brief_title>Effect of Diet on Gulf War Illness</brief_title>
  <official_title>Effect of Diet on Gulf War Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ashok Tuteja</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Salt Lake City Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fermentable Oligo-, Di and Mono-saccharides And Polyols (FODMAPs) are carbohydrates that are&#xD;
      poorly digested in intestines. The undigested carbohydrates are fermented in the colon by gut&#xD;
      bacteria. Fermentation of these carbohydrates can lead to diarrhea, gas and distension of the&#xD;
      colon. Low FODMAP diet effect may be mediated by changing the gut bacteria and/or by&#xD;
      production of chemicals that influence Veteran's intestines which then result in reduced&#xD;
      disease symptoms.&#xD;
&#xD;
      The goal of this study is to compare a low FODMAP (modified healthy) diet to a high FODMAP&#xD;
      (typical healthy) diet for effect on Veterans with IBS and symptoms of Gulf War illness.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design This will be a prospective, blinded randomized clinical trial with two parallel&#xD;
      groups. There will be 1-week screening period, 3-week diet treatment and, follow-up one month&#xD;
      later while Veterans choose their own diet.&#xD;
&#xD;
      Veterans who were deployed and served in Operation Desert Storm and Desert Shield will be&#xD;
      recruited to participate.&#xD;
&#xD;
      The two study diets to be provided to the Veterans and compared are:&#xD;
&#xD;
      Low FODMAP (modified healthy) diet:&#xD;
&#xD;
      High FODMAP (typical healthy) diet:&#xD;
&#xD;
      The FODMAP content of this diet will be higher than low FODMAP diet.&#xD;
&#xD;
      All questionnaires will be answered and measurements performed at baseline, end of treatment&#xD;
      and at follow-up visits.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in self-reported global Bowel Symptom Score</measure>
    <time_frame>Baseline and 3 Weeks</time_frame>
    <description>Change in bowel symptom score after 3 weeks of treatment with a Low FODMAP diet or High FODMAP diet.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported Irritable Bowel Syndrome Quality of Life (IBS-QOL) score</measure>
    <time_frame>Baseline and 3 Weeks</time_frame>
    <description>Change in IBS-QOL score after 3 weeks of treatment with a Low FODMAP diet or High FODMAP diet.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Low FODMAP (modified healthy) Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low FODMAP diet for 3 weeks. Veterans will be provided a diet containing foods low in FODMAP.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High FODMAP (typical healthy) Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High FODMAP diet for 3 weeks. Veterans will be provided a typically healthy diet following US Dietary Guidelines, containing foods high in FODMAPs</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low FODMAP Diet</intervention_name>
    <description>Diet low in foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols</description>
    <arm_group_label>Low FODMAP (modified healthy) Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High FODMAP Diet</intervention_name>
    <description>Typical diet of foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols</description>
    <arm_group_label>High FODMAP (typical healthy) Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Gulf War Veterans&#xD;
&#xD;
          -  Men and women age 25-90 years&#xD;
&#xD;
          -  Gulf War Illness: Veterans will have Rome III criteria for IBS and two or more of the&#xD;
             non-intestinal symptom groups (chronic-once a week or more often-fatigue, insomnia,&#xD;
             joint pains, general stiffness, and headache, neurological an mood, respirator and&#xD;
             skin symptoms)&#xD;
&#xD;
          -  Symptoms of &gt; 6 months duration&#xD;
&#xD;
          -  No significant findings on physical examination, complete blood count and clinical&#xD;
             chemistry panel&#xD;
&#xD;
          -  Normal gross appearance of the colonic mucosa (small colon polyps not an exclusion&#xD;
             criteria)&#xD;
&#xD;
          -  Veterans with psychological disorders will not be excluded but will be identified for&#xD;
             sub-group analysis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current evidence of any lower gastrointestinal disorder such as celiac disease or&#xD;
             inflammatory bowel disease&#xD;
&#xD;
          -  Clinically significant chronic disease: HIV, cardiac, pulmonary, hepatic or renal&#xD;
             dysfunction&#xD;
&#xD;
          -  Presence of Giardia antigen, and Clostridium difficile toxin in stool&#xD;
&#xD;
          -  Current history of drug or alcohol abuse&#xD;
&#xD;
          -  Investigator perception of patient's inability to comply with study protocol&#xD;
&#xD;
          -  Recent change in gastrointestinal medications&#xD;
&#xD;
          -  Subject is currently participating in another research protocol. These subjects will&#xD;
             be allowed to enroll after a washout period of one month.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashok K Tuteja, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>George E. Wahlen VA Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jaya Vijayan, MBBS</last_name>
    <phone>801-582-1565</phone>
    <phone_ext>4019</phone_ext>
    <email>jaya.vijayan@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>George E Wahlen VA Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashok K Tuteja, MD, MPH</last_name>
      <phone>801-582-1565</phone>
      <phone_ext>4019</phone_ext>
      <email>ashok.tuteja@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Jaya Vijayan</last_name>
      <phone>801-581-7802</phone>
      <email>jaya.vijayan@hsc.utah.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>August 24, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2016</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>VA Salt Lake City Health Care System</investigator_affiliation>
    <investigator_full_name>Ashok Tuteja</investigator_full_name>
    <investigator_title>Professor Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Gulf War Illness</keyword>
  <keyword>Diet</keyword>
  <keyword>IBS</keyword>
  <keyword>FODMAP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

